Amikacin in neonates: dosing recommendations should be based on both pharmacokinetics and dynamics.
Allegaert
K
K
Sherwin
C M
CM
D000583:Amikacin / Q000008:administration & dosage / Q000493:pharmacokinetics*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004334:Drug Administration Schedule; D054796:Drug Dosage Calculations; D016903:Drug Monitoring; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn / Q000378:metabolism; D007234:Infant, Premature / Q000378:metabolism; D008657:Metabolic Clearance Rate
D000900:Anti-Bacterial Agents; D000583:Amikacin